Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Felix Baker currently holds 7,955,916 shares of SYNAGEVA BIOPHARMA CORP (GEVA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Felix Baker has been a net buyer of GEVA stock. They have purchased $1.6B and sold $679.1M worth of shares.
Felix Baker's most recent insider trade was on Dec 11, 2025, when they purchased 1,838,621 shares at $86.00 per share.
Felix Baker serves as Executive at SYNAGEVA BIOPHARMA CORP (GEVA). They have executed 1261 insider transactions totaling $2.3B over their tenure at the company.
Felix Baker holds the position of Executive at SYNAGEVA BIOPHARMA CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Felix Baker has shown a buying trading pattern, with $1.6B in total purchases and $679.1M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Felix Baker was on Dec 11, 2025, when they purchased $158.1M worth of KYMR shares. This transaction involved 1,838,621 shares at $86.00 per share.
Felix Baker currently owns 7,955,916 shares of SYNAGEVA BIOPHARMA CORP (GEVA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Felix Baker's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Felix Baker has 1261 Form 4 filings on record as an insider at SYNAGEVA BIOPHARMA CORP.
Set alerts for Felix Baker and 40,000+ other insiders.